{"nctId":"NCT00498615","briefTitle":"A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon","startDateStruct":{"date":"2007-04"},"conditions":["Raynaud","Scleroderma"],"count":17,"armGroups":[{"label":"Fasudil 80 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Fasudil"]},{"label":"40 mg Fasudil","type":"EXPERIMENTAL","interventionNames":["Drug: Fasudil"]},{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Fasudil"]}],"interventions":[{"name":"Fasudil","otherNames":["No other name found"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* diagnosis of scleroderma\n* definite Raynaud's\n\nExclusion Criteria:\n\n* symptomatic orthostatic hypotension\n* evidence of current malignancy\n* active ischemic digital ulcer and/or tissue gangrene\n* history of sympathectomy at any time\n* upper extremity deep vein thrombosis or lymphedema within 3 months of the study\n* recent surgical procedure requiring general anesthesia\n* current alcohol or illicit drug use\n* use of any investigational drug within 30 days of the study sessions\n* pregnancy or current breast feeding\n* subjects felt by the investigators to active disease that would affect their ability to safely participate in the study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Time to Recover 50% of Fall in the Baseline Skin Temperature.","description":"The time to recover 50% of the drop from baseline (prechallenge) skin temperature was derived for each subject for each cold challenge. After each of 3 study interventions received by each participant. Each participant received Fasudil 4o mg, 80 mg and placebo in a randomized sequence blinded to the participant and researchers.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"3.2"},{"groupId":"OG001","value":"8.2","spread":"3.0"},{"groupId":"OG002","value":"7.9","spread":"3.1"}]}]}]},{"type":"SECONDARY","title":"The Blood Flow by Laser Doppler Scans of the Fingers","description":"The measurement of the blood flow of participants prior to cold challenge 2 hours after receiving study.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"138.3","spread":"55.1"},{"groupId":"OG001","value":"134.1","spread":"73.4"},{"groupId":"OG002","value":"122.6","spread":"57.6"}]}]}]},{"type":"PRIMARY","title":"Time to Recover to 70% of Fall in the Baseline Skin Temperature After Cold Challenge.","description":"The time to recover 70% of the drop from baseline (prechallenge) skin temperature was derived for each subject for each cold challenge. After each of 3 study interventions received by each participant. Each participant received Fasudil 4o mg, 80 mg and placebo in a randomized sequence blinded to the participant and researchers.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.1","spread":"10.8"},{"groupId":"OG001","value":"15.0","spread":"9.4"},{"groupId":"OG002","value":"18.2","spread":"10.7"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":[]}}}